Pharmacology

Action Mechanism of Action Reference
HYDROLYTIC ENZYME L-arginine hydrolytic enzyme

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Sarcoma 3 D012509 ClinicalTrials
Carcinoma, Hepatocellular 3 D006528 ClinicalTrials
Small Cell Lung Carcinoma 2 D055752 ClinicalTrials
Mesothelioma 2 D008654 ClinicalTrials
Lymphoma, Non-Hodgkin 2 D008228 ClinicalTrials
Mesothelioma 2 D008654 ClinicalTrials
Leukemia, Myeloid, Acute 2 D015470 ClinicalTrials
Melanoma 2 D008545 ClinicalTrials
Glioblastoma 2 D005909 ClinicalTrials
Non-alcoholic Fatty Liver Disease 2 D065626 ClinicalTrials
Neoplasms 1 D009369 ClinicalTrials
Breast Neoplasms 1 D001943 ClinicalTrials
Prostatic Neoplasms, Castration-Resistant 1 D064129 ClinicalTrials
Pancreatic Neoplasms 1 D010190 ClinicalTrials
Carcinoma, Non-Small-Cell Lung 1 D002289 ClinicalTrials
Uveal Melanoma 1 D000098943 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL3137346
FDA SRS 0B7PYQ9YRT